| Stage | MCD | % of rev | BJRI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.1B | 100.00% | $389M | 100.00% | MCD ×18.25 |
| Gross profit | $4.3B | 60.30% | $155M | 39.97% | MCD +20.3pp |
| Operating income | $3.3B | 47.02% | $18M | 4.74% | MCD +42.3pp |
| Pre-tax income | $2.9B | 41.36% | $19M | 4.89% | MCD +36.5pp |
| Net income | $2.4B | 33.27% | $19M | 4.83% | MCD +28.4pp |
| Stage | MCD | BJRI | Gap · A − B |
|---|---|---|---|
| Revenue | $7.1B100.00% | $389M100.00% | MCD ×18.25 |
| Gross profit | 60.30%$4.3B | 39.97%$155M | MCD +20.3pp |
| Operating income | 47.02%$3.3B | 4.74%$18M | MCD +42.3pp |
| Pre-tax income | 41.36%$2.9B | 4.89%$19M | MCD +36.5pp |
| Net income |
| 33.27%$2.4B |
| 4.83%$19M |
| MCD +28.4pp |
No disclosed counterparties: BJRI.
None